Conduit Pharmaceuticals Inc. 8-K Report: Key Financial Insights & Stock Updates

Based on the provided section of the financial report, here are the key insights and important information extracted:

1. Entity Identification:

• Company Name: Conduit Pharmaceuticals Inc.
• SEC CIK Number: 0001896212.
• IRS Employer Identification Number (EIN): 87-3272543.

2. Filing Type:

• Form: 8-K (Current Report).
• Filing Date: December 12, 2024.

3. Contact Information:

• Address: 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123.
• Phone: (760) 471-8536.

4. Stock Information:

• Class of Stock: Common Stock with a par value of $0.0001 per share.
• Ticker Symbols:
• • Common Stock: CDT (listed on NASDAQ).
  • Redeemable Warrants: CDTTW (listed on NASDAQ).
• Redeemable Warrants: Each warrant is exercisable for one share of common stock at an exercise price of $11.50.

5. Contextual Information:

• Reporting Period: The report pertains to a specific date, December 12, 2024, indicating that it may include information relevant to that day specifically.

6. Units of Measurement:

• The financial figures are reported in USD and shares, indicating the company's stock performance and financial metrics are denominated in these units.

7. Key Financial Elements:

• The report includes references to specific financial instruments (common stock and redeemable warrants) that may impact equity structure and capital raising strategies for Conduit Pharmaceuticals.

This analysis provides a concise overview of the pertinent details in the financial report, which can be useful for investors, analysts, and stakeholders in assessing the company's current status and offerings.